GENERALIZED MYASTHENIA GRAVIS

This study tested whether a drug called rozanolixizumab could help adults with generalized myasthenia gravis, a disease that causes severe muscle weakness. Researchers compared the drug to a placebo in 200 participants over 43 days to see if it improved their ability to perform d…

This study tested whether people with generalized myasthenia gravis (gMG) could safely give themselves their medication at home after training. Researchers taught 62 participants how to use two different injection methods and monitored their success and safety. The goal was to ma…

This study tested if people with generalized myasthenia gravis (gMG), a chronic autoimmune disease that causes muscle weakness, could safely switch from receiving their medication through regular intravenous (IV) infusions at a clinic to giving themselves a daily injection (ziluc…

This study tested whether people with generalized myasthenia gravis (a condition causing muscle weakness) could safely and effectively give themselves their medication using a new auto-injector device at home. Thirty-one adults who were already taking the medication zilucoplan pa…

This study tested the long-term safety and effectiveness of a medication called efgartigimod, given as an injection under the skin, for people with generalized myasthenia gravis (gMG). It involved 184 adults who had previously benefited from the treatment in earlier studies. The …

This study tested whether giving a medication called efgartigimod continuously or in cycles works better for people with generalized myasthenia gravis, a condition that causes muscle weakness. The trial involved 69 adults who received the medication for up to 138 weeks. Researche…